A web tool for finding gene candidates associated with experimentally induced arthritis in the rat

Open Access

Research article

A web tool for finding gene candidates associated with

experimentally induced arthritis in the rat

Lars Andersson

_{, Greta Petersen}

_{, Per Johnson}

_{and Fredrik Ståhl}

1_{Department of Cell and Molecular Biology – Genetics, Goteborg University, Sweden} 2_{School of Health Sciences, University College of Borås, Borås, Sweden}

Corresponding author: Lars Andersson, Lars.Andersson@gen.gu.se

Received: 2 Dec 2004 Revisions requested: 4 Jan 2005 Revisions received: 20 Jan 2005 Accepted: 24 Jan 2005 Published: 18 Feb 2005

Arthritis Research & Therapy 2005, 7:R485-R492 (DOI 10.1186/ar1700) This article is online at: http://arthritis-research.com/content/7/3/R485 © 2005 Andersson et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Rat models are frequently used for finding genes contributing to the arthritis phenotype. In most studies, however, limitations in the number of animals result in a low resolution. As a result, the linkage between the autoimmune experimental arthritis phenotype and the genomic region, that is, the quantitative trait locus, can cover several hundred genes. The purpose of this work was to facilitate the search for candidate genes in such regions by introducing a web tool called Candidate Gene Capture (CGC) that takes advantage of free text data on gene function. The CGC tool was developed by combining genomic regions in the rat, associated with the autoimmune experimental arthritis phenotype, with rat/human gene homology data, and with descriptions of phenotypic gene effects and selected keywords. Each keyword was assigned a value, which was used for ranking genes based on their description of phenotypic gene effects. The application was implemented as a web-based tool and made public at http://ratmap.org/cgc. The CGC application

ranks gene candidates for 37 rat genomic regions associated with autoimmune experimental arthritis phenotypes. To evaluate the CGC tool, the gene ranking in four regions was compared with an independent manual evaluation. In these sample tests, there was a full agreement between the manual ranking and the CGC ranking for the four highest-ranked genes in each test, except for one single gene. This indicates that the CGC tool creates a ranking very similar to that made by human inspection. The exceptional gene, which was ranked as a gene candidate by the CGC tool but not in the manual evaluation, was found to be closely associated with rheumatoid arthritis in additional literature studies. Genes ranked by the CGC tools as less likely gene candidates, as well as genes ranked low, were generally rated in a similar manner to those done manually. Thus, to find genes contributing to experimentally induced arthritis, we consider the CGC application to be a helpful tool in facilitating the evaluation of large amounts of textual information.

Introduction

Rheumatoid arthritis (RA) is an autoimmune disease charac-terised by chronic inflammation of the joints. The prevalence of RA is 0.5 to 1% in many populations [1] and is about 2.5 times higher in women [2]. RA has a very complex genetic basis, and the combination of genetic and environmental causative fac-tors makes it hard to study. The genetic contribution to RA susceptibility is estimated to be between 30% and 50%, of which the major histocompatibility complex accounts for about one-third [3].

Animal models provide a valuable tool for finding genes con-tributing to the susceptibility to and severity of RA. Rats are very useful for this purpose because autoimmune experimental

arthritis phenotypes can be induced in susceptible strains by several agents, such as collagen, pristane, oil, streptococcal cell wall and even adjuvant alone [4-6]. Intercrosses of such susceptible rat strains with resistant strains are used for estab-lishing linkage between genetic markers and quantitative traits distinguishing the arthritis phenotype. Statistically valid linkage between such genomic regions and measurements of quanti-tative traits are called quantiquanti-tative trait loci (QTLs). More than 40 QTLs that regulate experimentally induced arthritis have been identified in different rat crosses [7]. Most of these QTLs are several megabases in size, containing many possible gene candidates. Several experimental strategies are used to nar-row these regions, and these attempts almost always are

combined with the retrieval of potential candidate genes found in different databases.

Information about RA and related genome data is available in several different forms, from raw data to descriptive text. One important difference between raw data and data based on human evaluation is that human evaluation often yields an interpretation that gives meaning to the data. Thus, human considerations bring an added value to genome data, which makes textual description an important source for investigating gene function. However, the amount of free text about RA is growing very fast, so there is an increasing need for develop-ing a tool to help scientists distdevelop-inguish relevant information from background noise. To facilitate this kind of data mining, we have created a tool, the Candidate Gene Capture (CGC) application, that makes keyword-based searches on textual information for genes situated within selected human chromo-somal intervals that are homologous to a given rat QTL. Depending on the connection to RA, the keywords are allo-cated different values. The values for all matching keywords are summarised for each gene, the final values indicating which genes might be good candidates for contributing to the arthritis phenotype. When evaluated, this approach produces similar rankings to those done manually. In addition, this approach also manages to predict several candidate genes that are already established in the literature. Thus, the CGC application is a helpful tool for finding candidate genes asso-ciated with experimentally induced arthritis in rat.

Materials and methods

The focus of this work is the development of a web-based tool that facilitates the identification of potential gene candidates that contribute to experimentally induced autoimmune arthritis. The application, called CGC, was created by combining QTL regions in rat with human gene homology data, descriptions of phenotypic gene effects and selected keywords.

QTL data

Data describing 37 experimentally induced autoimmune arthri-tis QTLs in rat were obtained from the RatMap database [7]. These data were originally collected from experimentally induced inflammatory arthritis in rat strains susceptible to the following inducing agents: pristane, collagen, streptococcal cell wall, oil or adjuvant alone. Accordingly, the resulting QTLs are named Pristane-induced arthritis (Pia), Collagen-induced arthritis (Cia), Streptococcal cell wall-induced arthritis (Scwia), Oil-induced arthritis (Oia) and Adjuvant-induced arthritis (Aia).

The QTL data retrieved from RatMap include the locus symbol, a QTL description, the chromosomal position and flanking markers defining the borders of the QTL. The range of each QTL was based on the LOD score thresholds suggested in the corresponding papers. These data were stored in a MySQL table labelled 'QTL'.

Gene homology data

Human gene data were assembled primarily from National Centre for Biotechnology Information (NCBI) [8] and the Uni-versity of California Santa Cruz genome browser [9]. The genome information from NCBI consisted of official gene sym-bol, chromosome number, Locus Link ID, Online Mendelian Inheritance in Man (OMIM) ID, human Genome Database (GDB) accession ID and Refseq ID. Sequence positions were obtained exclusively from the University of California Santa Cruz genome browser, comprising transcript start/stop, codon start/stop, exon start/stop and number of exons in each gene. From this set of data, a table of human genes ordered by codon start was generated and labelled 'HsRn'.

To find orthologous gene pairs between rat and human, 1,464 chromosomally localised rat genes were obtained from Rat-Map. About 1,000 of these genes had a known homologous gene mapped in human. The orthologous rat/human gene pairs were characterised by the human data already present in table 'HsRn' together with the official rat gene symbol, rat chromosome number and RatMap ID.

Two flanking markers define each QTL used in this study. To find a human sequence homologous to a rat QTL region, an integrated linkage map containing rat genes and polymorphic DNA markers was used http://ratmap.org/ gene_mapping_data/integrated_linkage_maps/. For each QTL a pair of rat genes (obtained from the integrated linkage map) that were localised at, or close to, the two markers flank-ing the QTL and orthologous to human genes, was selected. The human chromosomal interval defined by these two orthol-ogous genes was expected to contain a sequence homolo-gous to the rat QTL. Because the homolohomolo-gous QTL interval often contained segments from more than one human chromo-some, all orthologous rat/human gene pairs within each QTL were used to find smaller human chromosomal segments to comprise the total list of human genes confined within the homologous region. Information on rat and human gene sym-bols, chromosomal positions and codon start for all genes included in the homologous interval (obtained from table 'HsRn') was stored in QTL-specific tables labelled with the same symbol as the corresponding QTL.

Downloading gene function data

The OMIM database [10] contains a comprehensive record of gene function and clinical data, which was used as a source for keyword querying in the CGC application. For each human gene within the selected intervals, gene function information was downloaded from OMIM and stored in a table labelled 'OMIMdata'.

Selecting keywords and running the application

homologous QTL region, selecting and ranking keywords, and searching OMIM text for selected keywords.

Finding a QTL of interest

The first step in finding candidate genes for a specific QTL is to choose a QTL of interest. To make this possible, we simply made the QTL database table directly available through a web interface. In this way, the user can access all QTLs in our data-base by searching for the locus symbol, the chromosome number and/or a descriptive text. The resulting QTLs are pre-sented, together with a brief description obtained from the QTL table.

Displaying the rat/human homologous QTL region

Next, the user can select the preferred QTL. The resulting web page presents all rat/human gene pairs within the chosen rat QTL region, together with all human genes in the homologous human genomic region that are found in OMIM. These data are obtained from the corresponding 'QTL-specific' table.

Thus, all rat genes within a selected QTL and all genes within the homologous human genomic region are displayed. Because the human genome is better characterised than the rat genome, more human genes are usually displayed.

Selecting and ranking of keywords

For all arthritis QTLs a total of 49 default keywords were cho-sen. Most keywords were obtained by selecting all terms found directly under the MeSH (Medical Subject Headings) terms 'autoimmune diseases' and 'rheumatoid arthritis' in the PubMed MeSH-term database [11]. Some of these terms were truncated to optimise the querying process. In addition, a set of keywords frequently used in arthritis-related literature was added to the default keyword list.

To estimate the relative importance of the default keywords in relation to arthritis, each keyword was given a value depending on its relevance to arthritis. This relevance index was calcu-lated as the number of PubMed abstracts containing both the keyword and the word 'arthritis' divided by the total number of abstracts containing the keyword alone. The relevance indices were multiplied by 100 to generate the final keyword values as percentages.

The application also allows the user to add up to 10 keywords of his or her own choice, and the corresponding keyword val-ues are automatically generated on the basis of the same prin-ciple as for the default keyword values. Optionally, the user can overrule all keyword values, including the default ones.

Searching OMIM text for selected keywords

When searching a QTL for all the default keywords, alterna-tively deselecting unwanted ones and/or adding new ones, the keyword values for all keywords found within each OMIM text (locally stored in the table 'OMIMdata') will be summarised. To

take advantage of the large amount of knowledge concerning the human genome, records in OMIM for all genes within the human homologous segment are used in the search, including genes not present in the rat gene list. For each gene, the total sum of all keyword values will be displayed, which indicates its relevance as a candidate gene. Each keyword is only counted once, independently of the number of times it occurs within a given OMIM text.

Results

In the CGC application presented in this paper, all known rat genes within a selected QTL, along with all human genes within the homologous interval, are retrieved and displayed from a table that has the same name as the selected QTL. A list with an array of 49 selectable arthritis related keywords is presented together with their respective keyword values. Up to 10 additional keywords can be added and their keyword val-ues are automatically calculated. When performing a search, the textual information for each human gene stored in the table 'OMIMdata' is scanned for all selected keywords. The genes and all keywords found in the accompanying text are dis-played, together with the sum of all matching keyword values.

To estimate whether the CGC application was able to rank candidate genes in fashion similar to human evaluations, gene descriptions for four randomly selected QTL regions (Cia4,

Cia10, Cia14 and Cia17) were surveyed manually. For all

genes within the selected QTL regions, we compared the out-come of the CGC gene ranking with our own manual evalua-tion of each OMIM text. The manual rating was made without knowledge of the CGC ranking. To put the application and the manual inspection at a similar level, we tried to base our eval-uation on the written OMIM texts only, without taking other information into account. In the manual inspection the OMIM texts were divided into five different classes: (1) obvious gene candidate, (2) likely gene candidate, (3) possible gene candi-date, (4) unlikely gene candidate and (5) gene without relevance.

In addition, the genes that were ranked as high by the CGC application were further scrutinised in an extensive analysis of related papers not found in the OMIM reference lists. Finally,

the NCF1 gene was studied in detail.

Cia4

IFNG (interferon-

γ

IFNG was identified by the CGC application on the basis of

10 different keywords: 'rheumatoid', 'HLA', 'sjogren', 'T cell', 'mhc', 'lymphocyte', 'antigen', 'cytokine', 'arthritis' and 'infecti'.

IFNG has been shown to be closely associated with RA. In a

study of 99 patients with RA of different severity, susceptibility to, and severity of, RA was shown to be related to a microsat-ellite polymorphism within the first intron of the gene encoding interferon-γ [12].

IL22 (interleukin-22), CGC points 14.1, CGC ranking 2, manual rating 2

IL22 was selected by the keywords 'inflam', 'T cell',

'lym-phocyte' and 'cytokine'. IL22 activates three different STAT

genes: STAT1, STAT3 and STAT5 [13]. RA synovial fibrob-lasts are relatively resistant to apoptosis and exhibit dysregu-lated growth. Retrovirus-mediated gene transfer of dominant-negative mutant STAT3 genes blocks the endogenous STAT3

expression in synovial fibroblasts from patients with RA, lead-ing to failure of growth in the cell culture and apoptosis [14].

A middle group of two genes was selected with the CGC application: MYC (CGC points 10.9, CGC ranking 3, manual rating 3) and HMGIC (CGC points 10.5, CGC ranking 4, manual rating 4).

Cia10

In total, 35 genes were ranked by the CGC tool. RPL7 and

NKFB1 were ranked as the two top candidates by the CGC

application. These two genes were also manually considered to be the most appropriate gene candidates for collagen-induced arthritis within this QTL.

NFKB1 (nuclear factor

κ

The very high point that NFKB1 obtained from the keyword query was in part due to the word 'arthritis' appearing in the corresponding OMIM text. Twelve other keywords were also found to be making a substantial contribution. According to the OMIM record, NFKB1 is a very strong gene candidate because the inappropriate activation of NKFB1 is known to be linked to inflammatory events associated with autoimmune arthritis [15].

RPL7 (ribosomal protein L7), CGC points 37.3, CGC ranking 2, manual rating 1

The RPL7 gene was rated second by the CGC application

mainly because of the keywords 'autoimmune', 'lupus' and 'ery-thematosus'. The RPL7 protein is reported to be a major autoantigen in systemic autoimmune arthritis [16].

A middle group of five genes was rated as relatively high by the CGC application: COL6A3 (CGC points 24.2, CGC ranking 3, manual rating 3), CSF1 (CGC points 17.4, CGC ranking 4,

manual rating 3), EDG1 (CGC points 12.5, CGC ranking 5, manual rating 5), VCAM1 (CGC points 11.3, CGC ranking 6, manual rating 2) and PAPSS1 (CGC points 9.3, CGC ranking 7, manual rating 3). Among these genes, CSF1 is a possible gene candidate because recent studies have shown that syn-ovial tissue in RA joints secretes CSF1 together with several other cytokines, which increases the osteoclast activity [17].

VCAM1 might also be a potential gene candidate because it

is expressed in endothelial cells of the blood vessels, facilitat-ing the adhesion of leucocytes [18]. EDG1 was a false predic-tion because the term 'HLA' matched an author (Hla T. Maciag T. J Biol Chem 1990;265:9308-13) and the term 'T cell' matched 'mutant cell'.

Cia14

In total, 16 genes were ranked by the CGC tool. The two top ranked genes according to the CGC application (IL15 and

HMOX1 ) were also the highest-rated genes in the manual

inspection.

IL15 (interleukin-15), CGC points 27.3, CGC ranking 1, manual rating 1

IL15 was ranked in first place by the CGC application. In the

corresponding OMIM text, IL15 is associated with the key-words 'autoimmun', 'inflam', 'T cell', 'lymphocyte', 'antigen', 'cytokine' and 'infecti', but not 'arthritis'. In a recent paper it was shown that increased serum levels of IL15 are found in patients with long-term RA [19].

HMOX1 (haem oxidase 1), CGC points 13.5, CGC ranking 2, manual rating 1

HMOX1 was ranked second by the CGC application with the

keywords 'anemia', 'hemolytic', 'inflam' and 'T cell'. HMOX1

has been shown to be involved in the treatment of RA with gold(I)-containing compounds. Gold(I) drugs selectively acti-vate a transcription factor (Nrf2/small Maf heterodimer), which induces the transcription of anti-oxidative stress genes,

includ-ing HMOX1, and inhibits inflammation [20].

A middle group of four genes were rated as relatively high by the CGC application: ITK (CGC points 9.7, CGC ranking 3, manual rating 2), NFATC3 (CGC points 9.7, CGC ranking 3, manual rating 3), AARS (CGC points 9.2, CGC ranking 5, manual rating 3) and KARS (CGC points 9.2, CGC ranking 5, manual rating 3).

Cia17

CD74, CGC points 27.7, CGC ranking 1, manual rating 3

The CD74 gene was ranked in first place by the CGC

appli-cation because of results from six different keywords: 'antigen', 'HLA', 'immunoglobulin', 'T cell', 'MHC' and 'inflam'. In a recent paper by Leng and colleagues [21], not present in the OMIM text, CD74 is reported to be required for macrophage migra-tion inhibitory factor (MIF)-induced activamigra-tion of the extracellu-lar signal-regulated kinase-1/2 mitogen-activated protein kinase cascade, cell proliferation, and prostaglandin E2 pro-duction. MIF is an upstream activator of monocytes/macro-phages and is centrally involved in the pathogenesis of RA and other inflammatory conditions.

SLC26A2 (solute carrier family 26 member 2), CGC points 24.2, CGC ranking 2, manual rating 2

SLC26A2 was associated with the keyword 'joint'. SLC26A2

is an anion transporter responsible for four recessively inher-ited chondrodysplasias: multiple epiphyseal dysplasia (MED) [22], diastrophic dysplasia (DTD) [23], atelosteogenesis Type II (AO2) [24] and achondrogenesis type IB (ACG1B) [25]. However, although other forms of chondrodysplasias such as progressive pseudorheumatoid chondrodysplasia show symp-toms similar to those of RA, no clear link between SLC26A2

and RA can be concluded.

A middle group of four genes were ranked in positions 3 to 6 by the CGC application: NR3C1 (CGC points 16.5, CGC ranking 3, manual rating 2), SPINK5 (CGC points 14.2, CGC ranking 4, manual rating 3), IK (CGC points 14.1, CGC rank-ing 5, manual ratrank-ing 3) and CD14 (CGC points 12.8, CGC ranking 6, manual rating 2). Two of these genes might be related to RA. NR3C1 is significantly overexpressed in untreated patients with RA and in several clinical studies of inflammatory conditions, such as RA [26]. CD14 has been reported to be associated with significantly elevated serum levels in patients with RA [27,28].

NCF1 (neutrophilic cytosolic factor 1)

The gene NCF1 is covered by both the Cia12 and Pia4 QTLs and was assigned a total point of 238.9 by the CGC applica-tion. This suggests that NCF1 is a strong gene candidate for RA. Indeed, NCF1 has been identified as a gene that has a naturally occurring polymorphism regulating arthritis severity in rats [29]. On looking at the OMIM text for NCF1, it is clear that most of the points come from the part of the text describing these particular findings. To evaluate the ability of the tool to predict genes that are reported to be related to the arthritis phenotype, the OMIM text was used in the form in which it existed before NCF1 was shown to be associated with arthri-tis; that is, the part of the OMIM text describing the association between NCF1 and arthritis was deleted before running the application. The resulting keyword sum was, as expected, much lower, with a total point of 10.8. However, these points were still sufficient to rank NCF1 as the top candidate of

Cia12 and Pia4 . Recently, the gene GUSB was updated at

OMIM, resulting in a total point of 30.7.

Discussion

A common feature of many genetically orientated RA studies is to find genes responsible for, or contributing to, one or sev-eral RA-related phenotypes. Typically, a genomic region might be known to be associated with a phenotype, but still there are usually many genes within such a region that might be possi-ble candidates. Specifically, when employing QTL analysis in rats, selecting gene candidates has become a recurrent part of the data analysis. An important part of the search for candi-date genes is checking the available bioinformatic resources; most often the written information describing gene function is very informative. The aim of this study was to facilitate this data mining by generating a web-based tool called Candidate Gene Capture (CGC), whose purpose is to identify potential candidate genes associated with experimentally induced arthritis phenotypes in rats.

In brief, the CGC application makes it possible to retrieve a large number of QTL regions previously described in the liter-ature. For each rat QTL, the homologous genomic region in humans is automatically displayed. All genes included in the corresponding human genomic interval can be queried for up to 49 default keywords and up to 10 keywords selected by the user. Each keyword is given a value based on an algorithm that estimates how closely related a keyword is to the term 'arthri-tis' according to their simultaneous occurrence in PubMed abstracts. OMIM records for human genes in a selected genomic region are ranked by their total keyword values; that is, the sum of the values for all keywords that hit a record. The higher the total keyword sum is, the more likely it is to be a gene candidate. The application can be accessed from the RatMap home page [7] or directly at http://ratmap.org/cgc.

Comparison of manual evaluation with CGC ranking

To estimate the ability of the CGC application to rank candi-date genes in a fashion similar to human evaluation, an inde-pendent manual inspection was made. Four randomly selected collagen-induced arthritis QTLs were used (Cia4,

Cia10, Cia14 and Cia17 ). The OMIM records used in the

CGC prediction were surveyed manually and rated on a scale from 1 to 5. Comparing the manual and CGC ratings, it was found that the two highest-ranked candidate genes in the CGC application for all QTLs studied were rated as high in the manual evaluation, with the exception of one gene, CD74 in

Cia17 . However, CD74 turned out to be a very likely gene

candidate when additional literature was surveyed (see below).

revealed that three of these genes (IL5, CD74 and HMOX1 ) had a strong association with RA. Many different keywords fit-ted each of the OMIM records associafit-ted with these three genes. Although none of these keywords had a very high key-word value (ranging from 1.6 to 9.7), the resulting keykey-word sums (IL15, 27.3; CD74, 22.3; HMOX1, 13.5) still clearly diverged from the keyword sums of other genes within the same QTLs. Thus, the CGC application is able to predict can-didate genes from OMIM records even though the association with RA is not explicitly mentioned in the text.

In addition to the two highest-ranked genes in the four QTLs evaluated, we also designated a middle group of candidate genes that were ranked in positions 3 to 6 by the CGC appli-cation (except for Cia4, in which the middle group comprised genes ranked in positions 3 and 4). The remaining genes for each investigated QTL formed a separate group (the low group). Comparing the mean values of the CGC ranking with the manual ratings for these three groups (the two highest, the middle group and the low group), a general agreement was found in the ranking of candidate genes (Table 1). The only exception was the relatively low manually rated 'best two' group for Cia17, which is fully explained by the low manual rat-ing of CD74 . As described above, on closer inspection the manual rating of CD74 turned out to be too cautious.

Finally, gene records without any keyword hits at all were not found to be associated with RA in the manual inspection.

Thus, when the CGC prediction is compared with manual inspection, the conclusion is that the application makes a reli-able evaluation of the OMIM records for the four QTLs studied in detail. For three genes (IL5, CD74 and HMOX1 ) the CGC application estimated the gene records as being more inter-esting than the manual inspection, an estimation confirmed by recent papers not yet included in the OMIM reference list. This shows that the CGC application is a very helpful tool for find-ing gene candidates contributfind-ing to RA. Furthermore, the CGC application also seems to follow our manual interpreta-tion for genes that might be of interest (referred to as the

'mid-dle group') as well as for genes with no evident connection to RA.

Keywords

No clear-cut connection can be made between the absolute sum of keyword values and the relevance of candidate genes. However, our evaluation of the four Cia QTLs implies that the ranking of the genes within each QTL based on the keyword sums provides a good prediction of the best candidate genes. For example, in QTL region Cia12, NCF1 has been shown by Olofsson and colleagues to be involved in the regulation of arthritis severity in rats [29]. As expected, NCF1 also obtains a very high keyword sum (225.6), mainly because of the description of Olofsson's findings in the OMIM text. When this description is excluded from the OMIM record, the NCF1 key-word sum decreases to 10.8. This still made NCF1 the high-est-ranked gene in this QTL region. As exemplified above, the CGC application is able to find candidate genes even though their relatedness to RA is not explicitly mentioned in the text investigated. In the paper describing Olofsson's findings, the authors stated that they found the candidate gene approach distracting, even though they were facing a region that con-tained a small set of genes. This could very well be so, but when analysing the genes within a QTL it seems reasonable to start with the most likely candidate genes rather than with ran-domly picked ones, especially if the region contains a large number of genes. The CGC application makes an unbiased evaluation of genes within a region, indicating which are the most favourable ones to start analysing. Looking at the NCF1

example retrospectively, CGC would in fact have suggested

NCF1 as the most probable candidate gene, although this

might be a fortunate case.

Among the selected keywords, occasionally there were a few that gave false positives. One example is the word 'joint' (point 24.2), which at times referred to other terms, such as 'joint maximum LOD score'. For example, this caused the gene KEL

to be ranked highest (28.7) for the Aia2 QTL. Another example is 'T cell' (points 2.8), which can produce results such as mutant cell or that cell, as found in the OMIM record for EDG1

(Cia10 ). In addition, it was found that some keywords can be

Table 1

Comparison between manual evaluation and Candidate Gene Capture (CGC) rating

Best two Middle group Low group

QTL CGC Manual CGC Manual CGC Manual

Cia4 152.6 1.5 10.7 3.5 2.3 3.9

Cia10 128.5 1.0 14.9 2.0 3.6 3.9

Cia14 20.4 1.0 9.5 2.7 4.6 3.4

Cia17 26.0 2.5 14.4 2.5 4.9 3.8

misinterpreted as author names. EDG1, for example, was falsely predicted as a candidate gene partly because the term 'HLA' matched an author (Hla T. Maciag T. J Biol Chem 1990;265:9308-13).

Forty-nine keywords were selected, based on PubMed MeSH terms and other terms frequently found in the literature on RA. However, this might not be a completely exhaustive set of key-words and a user of the CGC tool might want to extend or exchange parts of this keyword list. To make this possible, the user can add up to 10 keywords of his or her own and can automatically obtain the corresponding keyword values calcu-lated. These keywords can be used alone or together with the whole or parts of the default keyword list. It should be empha-sised that there is really no harm in using a large number of keywords, because irrelevant keywords, such as 'and' or 'is', will get almost no keyword values, thus not disturbing the selecting process. In addition, the user is allowed to overrule all keyword values if preferred and enter values of his or her own choice.

Comparison with related databases

To our knowledge there are three databases other than CGC that address the problem of finding candidate genes for com-plex disorders.

GeneSeeker is a web-based tool that permits the user to search different databases simultaneously, given a known human genetic location and an expression or phenotypic pat-tern(s) [30]. Moreover, data from syntenic regions in mouse can be included in the queries. The tool is a general instrument that has its strength in the range of databases covered. How-ever, GeneSeeker has no means for prioritizing between the genes retrieved. Because the CGC tool is specifically adapted for arthritis models, much more keywords relevant to this phe-notype are available here although both applications permit the user to enter his or her own keywords.

POCUS (Prioritizing Of Candidate genes Using Statistics) is an application that rates genes on the basis of their similarity to a set of genes generally considered to be associated with a given complex trait [31]. The similarity is quantified by measur-ing the number of functional annotations (Gene Onthology terms or InterPro domain ID) and/or expression pattern terms and IDs in common (Unigene or NCBI). Although POCUS pri-oritizes between the gene candidates, the strategy is different from that used for CGC. The genes associated with a given trait are not restricted to a specific genomic region. However, the authors claim that the application might be extended to work in such a way. POCUS is not a web-based tool but can be downloaded.

G2D (candidate Genes To inherited Diseases) is another database accessible from the web [32]. G2D is built on a strategy resembling that of CGC. In brief, chemical terms have

here been given scores calculated in a similar fashion to that in CGC; that is, the simultaneous occurrence of chemical terms (MeSH-C) and pathological conditions (MeSH-D) in PubMed. For a given disease several pathological conditions were selected on the basis of a set of representative papers. These pathological conditions were then related to functional descriptions (Gene Ontology terms) by using RefSeq annota-tions (RefSeq-NCBI) as mediating links, and the degree of relatedness were represented by 'GO-scores'. A gene can be related to a given disease by calculating the average GO-score annotated for that gene. In many ways this approach resembles that described in this paper, although G2D depends on Gene Onthology terms instead of a full text. More-over, G2D uses the mean GO-score for rating genes rather than calculating the sum. As a consequence, a gene with a GO-score based on just a single Gene Ontology term is rated higher than a gene that is annotated for the same term together with additional Gene Ontology terms with lower scores. Furthermore, in contrast to CGC, the GD2 database is a static database in which no data input from the user is pos-sible, and at present no information on RA is available.

Future developments

As our next step we plan to evolve the CGC application to include other text-based resources, such as PubMed abstracts, Swiss-Prot descriptions and, as a complement, Gene Ontology terms. In addition, we are currently extending the CGC tool to include rat QTLs for metabolic disorders, mainly focused on diabetes mellitus type II. The long-term goal is that the CGC tool will be able to predict candidate genes for any given type of rat QTL, such as multiple sclerosis, blood pressure or obesity. The strategy used in CGC could also be applied on QTLs in other species, such as mouse or human.

Conclusion

We conclude that the excellent agreement between our man-ual evaluation and the rankings made by the CGC application for the four different QTLs tested (Cia4, Cia10, Cia14 and

Cia17 ), as well as the prediction of the NCF1 gene, clearly

show that this tool makes very reliable predictions. Conse-quently, we believe that the CGC tool can be of great use in facilitating the finding of gene candidates related to the arthri-tis phenotype.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

con-tributed with original ideas and took full part in the preparation of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This work was supported in part by the Swedish Medical Research Council, the SWEGENE Foundation, the Sven and Lilly Lawski Founda-tion, the Royal Society of Arts and Sciences in Goteborg, the Wilhelm and Martina Lundgren Research Foundation and the Royal Hvitfeldtska Foundation.

References

1. Felson DT: Epidemiology of rheumatic diseases. In Arthritis and Allied Conditions – A Textbook of Rheumatology Edited by: Koop-man WJ. Baltimore, MD: Williams & Williams; 1997:3-10. 2. Wilder RL: Rheumatoid arthritis: epidemiology, pathology, and

pathogenesis. In Primer on the Rheumatic Diseases 10th edition. Edited by: Schumacher HR Jr, Klippel JH, Koopman WJ. Atlanta: Arthritis Foundation; 1993:86-89.

3. Deighton CM, Walker DJ, Griffiths ID, Roberts DF: The contribu-tion of HLA to rheumatoid arthritis. Clin Genet 1989,

36:178-182.

4. Wilder RL, Griffiths MM, Cannon GW, Caspi R, Remmers EF:

Susceptibility to autoimmune disease and drug addiction in inbred rats. Are there mechanistic factors in common related to abnormalities in hypothalamic–pituitary–adrenal axis and stress response function? Ann NY Acad Sci 2000,

917:784-796.

5. Griffiths MM, Remmers EF: Genetic analysis of collagen-induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol Rev 2001,

184:172-183.

6. Holmdahl R: Dissection of the genetic complexity of arthritis using animal models. J Autoimmun 2003, 21:99-103.

7. RatMap, Rat Genome Database, Dept for Cell and Molecular Biology, Goteborg University, Sweden [http://ratmap.org] 8. Human Genome Resources, National Center for

Biotechnol-ogy Information, National Library of Medicine (Bethesda, MD)

[http://www.ncbi.nlm.nih.gov/genome/guide/human/]

9. Genome Bioinformatics Group at University of California Santa Cruz (UCSC) [http://genome.ucsc.edu/]

10. Online Mendelian Inheritance in Man, OMIM™. McKusick-Nath-ans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Infor-mation, National Library of Medicine (Bethesda, MD) [http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM]

11. PubMed, National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD) [http:// www.ncbi.nlm.nih.gov/pubmed/]

12. Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, Balshaw R, Keown PA: Association between dinu-cleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000, 356:820-825.

13. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000,

275:31335-31339.

14. Krause A, Scaletta N, Ji JD, Ivashkiv LB: Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol 2002,

169:6610-6616.

15. Chen F, Castranova V, Shi X, Demers LM: New insights into the role of nuclear factor-kappa-B, a ubiquitous transcription fac-tor in the initiation of diseases. Clin Chem 1999, 45:7-17. 16. Neu E, von Mikecz AH, Hemmerich PH, Peter HH, Fricke M,

Deicher H, Genth E, Krawinkel U: Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parame-ters. The SLE Study Group. Clin Exp Immun 1995,

100:198-204.

17. Gravallese EM: Bone destruction in arthritis.Ann Rheum Dis 2002, 61(Suppl 2):ii84-ii86.

18. Carter RA, O'Donnell K, Sachthep S, Cicuttini F, Boyd AW, Wicks IP: Characterization of a human synovial cell antigen: VCAM-1 and inflammatory arthritis. Immunol Cell Biol 2001,

79:419-428.

19. Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo D, Laffon A: Increased serum levels of interleukin-15 in rheumatoid arthritis with long-term disease. Clin Exp Rheumatol 2003, 21:639-642.

20. Kataoka K, Handa H, Nishizawa M: Induction of cellular antioxi-dative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds. J Biol Chem 2001, 276:34074-34081.

21. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R: MIF signal transduction initiated by binding to CD74. J Exp Med 2003, 197:1467-1476. 22. Superti-Furga A, Neumann L, Riebel T, Eich G, Steinmann B,

Spranger J, Kunze J: Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J Med Genet 1999,

36:621-624.

23. Hastbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, Hamilton BA, Kusumi K, Trivedi B, Weaver A: The diastrophic dysplasia gene encodes a novel sulfate trans-porter: positional cloning by fine-structure linkage disequilib-rium mapping. Cell 1994, 78:1073-1087.

24. Hastbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES: Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 1996, 58:255-262. 25. Superti-Furga A, Hastbacka J, Wilcox WR, Cohn DH, van der

Harten HJ, Rossi A, Blau N, Rimoin DL, Steinmann B, Lander ES, et al.: Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet 1996, 12:100-102.

26. Neeck G, Kluter A, Dotzlaw H, Eggert M: Involvement of the glu-cocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann NY Acad Sci 2002, 966:491-495.

27. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR: Reduc-tion of monocyte-macrophage activaReduc-tion markers upon anti-CD4 treatment: decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.Clin Exp Immunol 1993, 91:207-213.

28. Yu S, Nakashima N, Xu BH, Matsuda T, Izumihara A, Sunahara N, Nakamura T, Tsukano M, Matsuyama T: Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low con-centrations activate RA synovial fibroblasts. Rheumatol Int 1998, 17:237-243.

29. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R: Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003, 33:25-32.

30. van Driel MA, Cuelenaere K, Kemmeren PP, Leunissen JA, Brunner HG: A new web-based data mining tool for the identification of candidate genes for human genetic disorders. Eur J Hum Genet 2003, 11:57-63.

31. Turner FS, Clutterbuck DR, Semple CA: POCUS: mining genomic sequence annotation to predict disease genes.

Genome Biol 2003, 4:R75.